Daniel Patschan, Gerhard Schmalz, Wajima Safi, Friedrich Stasche, Igor Matyukhin, Oliver Ritter, Susann Patschan
{"title":"Acute Kidney Injury in Autoimmune-Mediated Rheumatic Diseases.","authors":"Daniel Patschan, Gerhard Schmalz, Wajima Safi, Friedrich Stasche, Igor Matyukhin, Oliver Ritter, Susann Patschan","doi":"10.14740/jocmr6149","DOIUrl":null,"url":null,"abstract":"<p><p>Acute kidney injury (AKI) is increasingly affecting hospitalized patients worldwide. Patients with inflammatory rheumatic diseases, although primarily impacted by functional impairment and sometimes structural damage to joints, bones, and muscle tissue, may also develop AKI during the course of their disease. This narrative review aimed to summarize potential causes of AKI and the associated disease patterns. The following databases were searched for references: PubMed, Web of Science, Cochrane Library, and Scopus. The search period covered from 1958 to 2024. Certain inflammatory rheumatic diseases increase the risk of AKI due to specific types of kidney disease. However, the most common conditions, such as rheumatoid arthritis and spondylarthritis, rarely cause AKI directly. Among the medications used for pain and sometimes disease activity control, nonsteroidal anti-inflammatory drugs (NSAIDs) can potentially induce AKI, even progressing to acute tubular necrosis. There is evidence that certain rheumatic diseases are associated with increased risk of AKI, independently of directly affecting kidney function or structure. However, the data on this topic are quite limited. AKI is a potentially significant issue for patients with inflammatory rheumatic diseases. Additional data on the increased risk of AKI, independent of direct kidney involvement, are needed.</p>","PeriodicalId":94329,"journal":{"name":"Journal of clinical medicine research","volume":"17 2","pages":"67-75"},"PeriodicalIF":1.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11835554/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical medicine research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jocmr6149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Acute kidney injury (AKI) is increasingly affecting hospitalized patients worldwide. Patients with inflammatory rheumatic diseases, although primarily impacted by functional impairment and sometimes structural damage to joints, bones, and muscle tissue, may also develop AKI during the course of their disease. This narrative review aimed to summarize potential causes of AKI and the associated disease patterns. The following databases were searched for references: PubMed, Web of Science, Cochrane Library, and Scopus. The search period covered from 1958 to 2024. Certain inflammatory rheumatic diseases increase the risk of AKI due to specific types of kidney disease. However, the most common conditions, such as rheumatoid arthritis and spondylarthritis, rarely cause AKI directly. Among the medications used for pain and sometimes disease activity control, nonsteroidal anti-inflammatory drugs (NSAIDs) can potentially induce AKI, even progressing to acute tubular necrosis. There is evidence that certain rheumatic diseases are associated with increased risk of AKI, independently of directly affecting kidney function or structure. However, the data on this topic are quite limited. AKI is a potentially significant issue for patients with inflammatory rheumatic diseases. Additional data on the increased risk of AKI, independent of direct kidney involvement, are needed.
急性肾损伤(AKI)越来越多地影响全球住院患者。炎症性风湿病患者,虽然主要受功能损害影响,有时关节、骨骼和肌肉组织的结构损伤,也可能在其病程中发生AKI。本综述旨在总结AKI的潜在原因和相关疾病模式。检索了以下数据库:PubMed、Web of Science、Cochrane Library和Scopus。搜索期从1958年到2024年。由于特定类型的肾脏疾病,某些炎症性风湿病会增加AKI的风险。然而,最常见的情况,如类风湿关节炎和脊柱炎,很少直接引起AKI。在用于疼痛和控制疾病活动的药物中,非甾体抗炎药(NSAIDs)可能诱发AKI,甚至发展为急性肾小管坏死。有证据表明,某些风湿性疾病与AKI风险增加相关,而不直接影响肾功能或肾脏结构。然而,关于这一主题的数据相当有限。AKI对于患有风湿性疾病的患者是一个潜在的重大问题。需要更多的数据来证明AKI风险的增加,且不直接累及肾脏。